Thirty-four NIDDM patients were given 4-month dietary control and / or oral hypoglycemic agent treatment and it showed that the GFR, kidney volume and UAE were partially reduced in 12 patients with improved metabolic control; 34例NIDDM患者经饮食控制和/或口服降糖药(OHA)治疗4个月后进行了复查,结果显示:12例代谢改善者的GFR、肾脏体积和UAE有不同程度的恢复;
Combination therapy with insulin and oral hypoglycemic agent for type ⅱ diabetes 胰岛素和口服降糖药(OHA)合用治疗Ⅱ型糖尿病
Clinical Application of Oral Hypoglycemic Agent(OHA) to Diabetes 糖尿病口服降糖药(OHA)的临床应用进展
Nateglinide is a novel oral hypoglycemic agent used in type 2 diabetes. It is absorbed and eliminated in short time and made the blood glucose of diet in physiological control. 那格列奈是一种新型的治疗2型糖尿病的口服药物,它能够被快速吸收和消除,从而使膳食时的血糖得到生理性控制。
Clinical Report on Correction of HbAlc Level in Diabetes ⅱ with Secondary Failure of Oral Hypoglycemic Agent(OHA) by Chinese Herbs 中药纠正口服降糖药(OHA)物继发失效Ⅱ型糖尿病HbAlc水平的临床报道